Retinal BioAge is associated with indicators of cardiovascular-kidney-metabolic syndrome in UK and US populations

Published

2026

Audience

Therapeutic Area

Content Type

AI Generated Summary*

A deep learning estimate of biological age from retinal photographs was tested against cardiovascular, kidney and metabolic markers in two cross-sectional cohorts aged 41 to 70: 5,476 UK Biobank participants from a general population and 9,786 EyePACS patients with diabetes, mostly Hispanic/Latino. Within five-year age bands, top and bottom quartiles of BioAgeGap (estimated minus chronological age) were compared. In UK Biobank, the top quartile had systolic pressure 8.01 mmHg higher and more hypertension (51.3% versus 30.0%), kidney disease (5.9% versus 3.9%) and diabetes (2.9% versus 1.5%). In EyePACS, HbA1c was 0.73% higher, eGFR 3.47 mL/min/1.73 m2 lower, kidney disease 35.8% versus 20.8% and any diabetic retinopathy 57.8% versus 9.4%, whereas obesity was less frequent in the top quartile.

*This summary was generated by AI and is published unedited. Oku does not alter these summaries. It may contain errors or omissions and is provided for general informational purposes only. Oku does not guarantee its accuracy, completeness, or reliability. For authoritative information, please refer to the original, peer-reviewed article.

At a glance

Authors
David Squirrell; Christopher Nielsen; Ehsan Vaghefi; Songyang An; Shima Moghadam; Song Yang; Li Xie; Atefeh Rahimi; Mary K. Durbin; Huiyuan Hou; Robert N. Weinreb; Michael V. McConnell
Publication
Scientific Reports
Keywords
Metabolic Syndrome, United Kingdom, United States, Cardiovascular Disease, Kidney Diseases, Retina
Year
2026
View primary source

This is the evidence

See where we take it next

Join the Network